|
Media Contact
Annette Ballou
Email
216.658.3999
|
|
|
|
|
Newsroom > News
|
|
|
IceCure, a publicly traded Israeli medical device company (TASE: ICCM), announced the establishment of its US headquarters in Cleveland. The company's IceSense3 system is an office-based cryoablation device for the minimally-invasive treatment of benign breast tumors and uterine fibroids. IceCure was originally backed by Bridge Investment Fund and Giza Ventures. It is the latest in a series of Israeli companies to locate US headquarters in the Cleveland region.
Click here to read more from IceCure.
|
|
|
|
|